Answers are grounded in this paper and cite their sources.
This study aimed to develop and evaluate machine learning models capable of predicting thrombocytopenia in patients with atrial fibrillation, with a focus on African clinical settings where this complication is underexplored despite its clinical importance. Real-world data were obtained from the AFRICA registry, a large multicenter database encompassing diverse patient profiles. Six algorithms were implemented and compared, including Decision Tree, Random Forest, XGBoost, Support Vector Machine, K-Nearest Neighbors, and Multi-Layer Perceptron. Stratified cross-validation was used to ensure robust evaluation based on accuracy, F1-score, AUC-ROC, Log Loss, and Matthews Correlation Coefficient. Model interpretability was enhanced using the SHAP method to identify the most influential predictors. Tree-based models performed best. On cross-validation, XGBoost reached 97.4%, F1 0.92, and AUC-ROC 0.98, and its performance was confirmed on an independent 20% holdout set (accuracy 93.75%, F1 0.857, AUC-ROC 0.9803). SHAP analysis highlighted platelet count, hemoglobin, creatinine, and glycemia as the strongest predictors, alongside clinical factors such as amiodarone therapy, intensive care admission, and depressive symptoms. High-performance, interpretable machine learning models can accurately forecast thrombocytopenia in African patients with atrial fibrillation. These findings provide a solid basis for the development of clinical decision support systems aimed at improving patient management and treatment outcomes. KEYWORDS AFRICA registry, clinical decision, hematology, model interpretability, multicenter cohort, supervised learning
No takes yet. Share an insight, caveat, or question.
Diabagaté et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: